New biologics and biosimilars approval guidelines in Mexico The Pharma Letter For example, Probiomed already sells six non-originator biologics, including Kikuzubam (rituximab), which is Probiomed's version of Roche's Rituxan/MabThera (rituximab). Last month, just before the new biocomparables guidelines took effect in Mexico, ... |
